Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

内ベータエンドルフィン

K M Foley, C E Inturrisi

    Lancet (London, England)
    |August 9, 1980
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Characterizing grassland fire activity in the Flint Hills region and air quality using satellite and routine surface monitor data.

    The Science of the total environment·2019
    Same author

    Neurologic pain syndromes in cancer patients.

    Journal of back and musculoskeletal rehabilitation·2014
    Same author

    Spinal mediators that may contribute selectively to antinociceptive tolerance but not other effects of morphine as revealed by deletion of GluR5.

    Neuroscience·2010
    Same author

    Induction of tyrosine hydroxylase mRNA by protein synthesis inhibitors in the rat adrenal.

    Molecular and cellular neurosciences·2009
    Same author

    Inflammatory pain-induced signaling events following a conditional deletion of the N-methyl-D-aspartate receptor in spinal cord dorsal horn.

    Neuroscience·2008
    Same author

    The role of N-methyl-D-aspartate (NMDA) receptors in pain and morphine tolerance.

    Minerva anestesiologica·2005
    Same journal

    Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

    Lancet (London, England)·2026
    Same journal

    Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

    Lancet (London, England)·2026
    Same journal

    Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial.

    Lancet (London, England)·2026
    関連記事をすべて見る